- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05781165
Application of Augmented Reality (AR) in HIV Self-test in Men Who Have Sex With Men Community
Objective: To apply augmented reality (AR) technology in HIV self-test and to assess its impacts in enhancing testing performance among men who have sex with men (MSM).
Design: Parallel randomised controlled, open label, trial. Block randomisation with a block size of 4 would be used to allocate the study arms.
Participants: men who have sex with men in Hong Kong
Intervention: Self-test assisted by AR vs self-test with instruction sheets
Main outcome measures: Effectiveness, usability, learnability, efficiency and satisfaction scores; rate of completion and result upload; acceptability of AR approach in assisting self-test
Anticipated results: 200 MSM would be recruited with 50 and 150 in control and intervention group, respectively. The scores in the intervention group are 10% higher than the control group. Proportion of satisfied participants in the intervention group is 10% more than the control group. AR approach is feasible and acceptable to MSM for assisting in HIV self-test.
Study Overview
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Secretariat
- Phone Number: +85222528812
- Email: ceid@med.cuhk.edu.hk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult men who have sex with men
- Has access to a smartphone with internet access
Exclusion Criteria:
- Unable to communicate in written Chinese or English
- Unable to give informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Participants in the intervention arm will be able to access the augmented reality page in the web app to perform the HIV self-test
|
Step-by-step 3D models displayed with augmented reality guiding the self-test procedures
|
No Intervention: Control
Participants in the control arm will be asked to follow the instruction sheet to perform the HIV self-test
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Confidence in performing the self-test
Time Frame: Month 3
|
Confidence in performing the self-test in a Likert scale of 1 (least confident) to 10 (most confident)
|
Month 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Usability of the augmented reality web app
Time Frame: Month 3
|
Score measured by system usability scale ranged from 0 to 100 (higher scores mean more usable)
|
Month 3
|
Usability of the augmented reality web app
Time Frame: Month 3
|
Score measured by single ease question ranged from 1 to 7 (higher scores mean easier)
|
Month 3
|
Usability of the augmented reality web app
Time Frame: Month 3
|
Score measured by after scenario questionnaire (average score of the 3-item questionnaire ranged from 1 to 7, higher scores mean more usable)
|
Month 3
|
Usability of the augmented reality web app
Time Frame: Month 3
|
Score measured by subjective mental effort questionnaire ranged from 0 to 150 (higher scores mean more difficult)
|
Month 3
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tsz Ho Kwan, PhD, Jockey Club School of Public Health and Primary Care
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MSS346R
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hiv
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Hospital Clinic of BarcelonaCompletedIntegrase Inhibitors, HIV; HIV PROTEASE INHIBSpain
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
Clinical Trials on Augmented reality
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
University of PittsburghNortheastern University; NSFRecruiting
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaCompletedCentral Line ComplicationCanada
-
Brigham and Women's HospitalWithdrawnPain | Infection | MalignancyUnited States
-
Stanford UniversityCompletedAcute Pain | Mobility Limitation | Spinal FusionUnited States
-
Wayne State UniversityEnrolling by invitationSpecific Phobia, AnimalUnited States
-
University of VirginiaRecruitingPain, Acute | Vocal Cord Paralysis | Laryngeal Neoplasms | Vocal Fold PolypUnited States
-
Universidad Peruana Cayetano HerediaCompletedHospitalized ChildPeru
-
University Hospital, Clermont-FerrandActive, not recruitingMyoma;Uterus | Adenomyoma of UterusFrance